This inventor holds 23 USPTO granted patents and 9 published patent applications. Top assignees: Cosmo Technologies Limited, Cosmo S.p.a.. Active years: 2004-2020.
Location History:
- Panama, PA (2004)
- Panama City, PA (2008)
- Cignese, IT (2008 - 2011)
- Gignese, IT (2008 - 2020)
Company Filing History:
Years Active: 2004-2020
Title: Innovator Massimo Pedrani: A Pioneer in Pharmaceutical Compositions
Introduction: Massimo Pedrani, hailing from Gignese, Italy, is an accomplished inventor with a remarkable portfolio of 23 patents. His work is primarily focused on the field of pharmaceutical compositions, particularly in enhancing the efficacy and user experience of oral medications.
Latest Patents: Among his latest innovations, Massimo has developed a controlled release and taste masking oral pharmaceutical composition. This invention introduces compositions that incorporate one or more active principles embedded within a sophisticated three-component matrix structure. This matrix utilizes successive amphiphilic, lipophilic, or inert matrices, which are finally integrated or dispersed in hydrophilic matrices. This innovative approach effectively controls the dissolution of the active ingredient, thereby modulating the release kinetics in the gastrointestinal tract, enhancing the therapeutic effectiveness of medications.
Career Highlights: Over the years, Massimo has made significant contributions in the pharmaceutical industry, particularly during his tenure at Cosmo Technologies Limited and Cosmo S.p.A. His inventions have not only advanced drug formulation techniques but have also significantly impacted patient compliance and satisfaction.
Collaborations: Throughout his career, Massimo has collaborated with notable colleagues such as Roberto Villa and Lorenzo Fossati. Their joint efforts have fostered advancements in drug delivery systems, emphasizing innovation and quality in pharmaceutical products.
Conclusion: Massimo Pedrani stands out as a key figure in the realm of pharmaceutical innovation. With an impressive portfolio of patents, his work continues to influence the development of advanced drug formulations. His dedication to improving patient experiences through technology sets a benchmark in the industry, promising a future where medication efficacy and tolerability reach new heights.